Incidence, Risk Factors and Outcome of Bloodstream Infections in Patients After Hematopoietic Stem-Cell Transplantation: A Single Center Study

Denis Niyazi; Ilina Micheva; Klara Dokova; Temenuga Stoeva

doi:10.1007/s12288-023-01645-2

Incidence, Risk Factors and Outcome of Bloodstream Infections in Patients After Hematopoietic Stem-Cell Transplantation: A Single Center Study

Indian J Hematol Blood Transfus. 2023 Apr 1;39(4):1-5. doi: 10.1007/s12288-023-01645-2. Online ahead of print.

Authors

Denis Niyazi^{1

2}, Ilina Micheva^{3

2}, Klara Dokova⁴, Temenuga Stoeva^{1

2}

Affiliations

¹ Laboratory of Clinical Microbiology, University Hospital "St. Marina", Varna, Bulgaria.
² Medical University - Varna, Varna, Bulgaria.
³ Clinical Hematology Clinic, University Hospital "St. Marina", Varna, Bulgaria.
⁴ Department of Social Medicine and Healthcare Organization, Medical University - Varna, Varna, Bulgaria.

PMID: 37362402
PMCID: PMC10066969 (available on 2024-10-01)
DOI: 10.1007/s12288-023-01645-2

Abstract

The bloodstream infections (BSIs) are among the most common infectious complications after hematopoietic stem-cell transplantation (HSCT), often associated with high mortality rates. The aim of this study was to evaluate the incidence, risk factors and outcome of BSIs in HSCT recipients from the Transplantation Center of the University Hospital in Varna, Bulgaria during the period January 2019-December 2021. The role of patient- and transplantation-related variables was studied as potential risk factors for BSIs and survival after HSCT. Seventy-four patients were included in the study. The cumulative incidence of BSIs was 35%. The mean period of BSI onset after HSCT was 8 days. The Gram-positive bacteria were more commonly isolated as causative agents (52.3%). The mortality rate 30 days after the diagnosis of BSI was 23%. Fecal colonization with multidrug-resistant (MDR) bacteria (p = 0.005) and pre-transplant BSI (p = 0.05) were associated with significantly increased risk for post-HSCT BSIs. The overall 4-month survival was 86.5%. A statistical significance was found between the type of the underlying disease (acute leukemia and lymphoma, p = 0.043), previous HSCT (p = 0.001) and 4-month survival. This study confirms that the fecal colonization with MDR bacteria before transplantation and pre-transplant BSIs are independent risk factors for the occurrence of BSI in the early period after HSCT. Pre- and posttransplant monitoring of the patient fecal colonization status with MDR organisms, could contribute considerably to the prevention and successful management of the infectious complications in patients after HSCT.

Keywords: Bloodstream infection; Hematopoietic stem-cell transplantation; Risk factors; Survival.

© The Author(s), under exclusive licence to Indian Society of Hematology and Blood Transfusion 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.